2020
DOI: 10.1016/s0016-5085(20)32047-3
|View full text |Cite
|
Sign up to set email alerts
|

Su1199 THE IMPACT OF BIOLOGICAL TREATMENT AND INFLAMMATORY BURDEN IN INFLAMMATORY BOWEL DISEASE ON THE GUT MICROBIOTA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…4 The diagnosis and treatment of UC are both complex and expensive. 5,6 The traditional drugs for the treatment of UC are aminosalicylic acid, glucocorticoid and immunosuppressant. Unsatisfactory clinical efficacy, poor tolerance, easy to relapse after withdrawal, and many adverse reactions limit their use.…”
Section: Introductionmentioning
confidence: 99%
“…4 The diagnosis and treatment of UC are both complex and expensive. 5,6 The traditional drugs for the treatment of UC are aminosalicylic acid, glucocorticoid and immunosuppressant. Unsatisfactory clinical efficacy, poor tolerance, easy to relapse after withdrawal, and many adverse reactions limit their use.…”
Section: Introductionmentioning
confidence: 99%
“…1 These complex interactions control inammatory responses, and dysregulation of these mechanisms and/or introduction of microorganisms that produce compounds that stimulate inammation can lead to disease. 2 Incidence of inammatory bowel diseases, such as Crohn's disease, continues to increase. 3 One contributing cause to these diseases is the makeup of the microbiome.…”
Section: Introductionmentioning
confidence: 99%